Geeta Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-01-2025
- Paid Up Capital ₹ 0.51 M
as on 02-01-2025
- Company Age 29 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 02-01-2025
About Geeta Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.51 M.
The company currently has active open charges totaling ₹1.00 M.
Omprakash Girdharilal, Rajashree Bajaj, and Priyanka Bajaj serve as directors at the Company.
- CIN/LLPIN
U01110MH1995PLC088452
- Company No.
088452
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 May 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Geeta Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Omprakash Girdharilal  | Director | 17-May-1995 | Current |
| Rajashree Bajaj | Director | 01-Apr-2007 | Current |
| Priyanka Bajaj | Director | 01-Apr-2007 | Current |
Financial Performance of Geeta Biotech.
Geeta Biotech Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Geeta Biotech?
In 2017, Geeta Biotech had a promoter holding of 99.61% and a public holding of 0.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Artsy Design Co Private LimitedActive 11 years 5 monthsRajashree Bajaj and Priyanka Bajaj are mutual person
Geeta Garden Consultants LlpActive 7 years 9 monthsOmprakash Girdharilal and Rajashree Bajaj are mutual person
- Geeta Doorwin Private LimitedActive 28 years 11 months
Omprakash Girdharilal and Rajashree Bajaj are mutual person
- Geeta Techno-Engineering LimitedActive 26 years 4 months
Omprakash Girdharilal, Rajashree Bajaj and 1 more are mutual person
- Geeta Building Constructions And Investments Private LimitedActive 37 years 5 months
Omprakash Girdharilal and Rajashree Bajaj are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
New India Co-Op. Bank Ltd Creation Date: 29 Jun 1999 | ₹1.00 M | Open |
How Many Employees Work at Geeta Biotech?
Unlock and access historical data on people associated with Geeta Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Geeta Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geeta Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
